brainfunction.jpg

Study Locations

If you think your child is eligible for the study, take the next step:

More information is also available at: clinicaltrials.gov, identifier NCT04895215.

Find a study location near you

All travel and other expenses for this study will be reimbursed.

us-map.jpg

UNITED STATES

 

ARIZONA

University of Arizona

Department of Pediatrics

PO Box 210158,

Room 510, Tucson, Arizona

85721

520-626-1994

jocelineserino@peds.arizona.edu

Southwestern Autism Research and Resource Center

2225 N 16th St, Phoenix, Arizona, 85006

602-340-8717

ACrisler@autismcenter.org

 

CALIFORNIA

University of California, Davis-MIND Institute

2825 50th St, Sacramento, California, 95817

916-703-0300

esbickel@ucdavis.edu

 

Langley Porter Psychiatric Institute

401 Parnassus Ave, San Francisco, California, 94122

415-476-7000

felicia.widjaja@ucsf.edu

 

Cortica Westlake Village

2625 Townsgate Rd, Westlake Village, California, 91361

805-413-3009

mpurdy@corticacare.com

 

CONNECTICUT

Yale University, Child Study Center
230 S Frontage Rd, New Haven, Connecticut, 06510 
203-688-5997
aniela.bordofsky@yale.edu

FLORIDA

CNS Solutions, Inc.
5200 Belfort Rd, Ste 420, Jacksonville, Florida, 32256 420
904-281-5757
sjandir@cnshealthcare.com

CNS Solutions, Inc.
618 E South St, Orlando, Florida, 32801 
407-425-5100
blittlejohn@cnshealthcare.com
Contact: Brad Littlejohn, MA, LMHC, CCRC

University of South Florida
3515 E Fletcher Ave, Tampa, Florida, 33613
813-821-8032
jsamson@usf.edu

ILLINOIS
AMR-Baber Research, Inc.
1460 Bond St, Naperville, Illinois, 60563 
630-272-4844
freeda@baberresearchgroup.com

LOUISIANA
LSU Health - Shreveport
1801 Fairfield Ave, Shreveport, Louisiana, 71101
318-681-6360
stephanie.saunders@lsuhs.edu

MASSACHUSETTS
Massachusetts General Hospital, Lurie Center
1 Maguire Road, Lexington, Massachusetts, 02421
781-860-1700
jmullett@mgh.harvard.edu

MICHIGAN
Neurobehavioral Medicine Group
4111 Andover Rd, Bloomfield Hills, Michigan, 48302
248-290-5400
catherinem@neurobmg.com

NEVADA
Clinical Research of Southern Nevada, LLC.
7351 Prairie Falcon Rd, Ste 160, Las Vegas, Nevada, 89128
702-838-0742
drann87@aol.com

NEW YORK
Nathan S. Kline Institute for Psychiatric Research
140 Old Orangeburg Rd, Orangeburg, New York, 10962
845-398-2184
melissa.breland@nki.rfmh.org

Richmond Behavioral Associates
4349 Hylan Blvd, Staten Island, New York, 10312
718-317-5522
sgooneratne@ergclinical.com

OHIO
Ohio State University, Nisonger Center
1581 Dodd Dr, Columbus, Ohio, 43210
614-685-3192
Jasmine.Sanders2@osumc.edu

VIRIGINIA
Carilion Medical Center
2017 S Jefferson St, Roanoke, Virginia, 24014
540-981-8025
brlewis@carilionclinic.org

aus_nz-map.jpg

AUSTRALIA

 

Queensland Children's Hospital

Centre for Clinical Trials in Rare Neurodevelopmental Disorders (CCTRND) 

62 Graham St, South Brisbane, Brisbane, Queensland, 4101

Phone: +61 (0)7 3069 7532

Email: CHQ_CCTRND@health.qld.gov.au

 

The Children's Hospital at Westmead

Corner Hawkesbury Road and, Hainsworth St, Westmead NSW 2145

Phone: +61 (0)2 9114 4189 (ext# 44189)

Email: zahava.ambarchi@sydney.edu.au

 

The Royal Children's Hospital

50 Flemington Rd, Parkville, Melbourne, Victoria, 3052

+61 3 9936 6756

+61 4 1174 5352

Email: kylie.crompton@mcri.edu.au

Email: laksha.alahakoon@mcri.edu.au

 

NEW ZEALAND

Optimal Clinical Trials,

Grafton Road, Grafton, Auckland 1010, New Zealand

+00 64 (9) 303 4987

Email: info@optimalclinicaltrials.com

“The lack of safe and effective treatment options for co-occurring conditions associated with ASD, such as irritability and anxiety, exacerbate the daily challenges faced by children and their families. I am encouraged by previous studies of AB-2004 and I look forward to assessing its potential as a safe alternative to atypical antipsychotics currently used to treat irritability associated with autism.” 

 

-Robert L. Hendren, D.O., professor, psychiatry, Weill Institute for Neurosciences at the University of California, San Francisco, School of Medicine, and a principal investigator for the AB-2004 Phase 2 trial

dr-robert-hendren-md-104-320x320-2x_edited.jpg